Jade Biosciences, Inc. (JBIO)

NASDAQ: JBIO · Real-Time Price · USD

23.81

+0.60 (2.59%)

At close: Aug 13, 2026, 4:00 PM EDT

23.81

0.00 (0.00%)

Pre-market: Aug 14, 2026, 4:00 AM EDT

Jade Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	28.07	20.42	21.41	17.19	14.62	8.04
Research & Development	136.67	93.12	53.19	64.22	38.62	14.99
Total Operating Expenses	164.74	113.54	74.6	81.41	53.24	23.02
Operating Income	-164.74	-113.54	-74.6	-81.41	-53.24	-23.02
Interest Income	11.67	7.78	5.04	5.95	1.83	0.07
Other Non-Operating Income (Expense)	-0.03	-21.58	-0.02	-0	-0.08	-0
Total Non-Operating Income (Expense)	11.59	-13.81	5.02	5.94	1.75	0.06
Pretax Income	-153.15	-127.35	-69.57	-75.47	-51.49	-22.96
Provision for Income Taxes	-0.09	-0.06	0.06	0.06	0.03	0
Net Income	-153.24	-127.41	-69.63	-75.52	-51.51	-22.96
Net Income to Common	-153.24	-127.41	-69.63	-75.52	-51.51	-22.96
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	53	31	1	1	1	0
Shares Outstanding (Diluted)	53	31	1	1	1	0
Shares Change	460.46%	3740.15%	8.55%	7.60%	99.06%	-
EPS (Basic)	-1.92	-3.19	-85.40	-100.45	-73.50	-65.45
EPS (Diluted)	-1.92	-3.19	-85.40	-100.45	-73.50	-65.45
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-123.57	-94.89	-71.2	-56.92	-39.32	-27.58
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-2.33	-3.03	-87.18	-75.66	-56.23	-78.52
EBITDA	-164.7	-113.52	-74.31	-81.31	-53.17	-23.01
EBIT	-164.74	-113.54	-74.6	-81.41	-53.24	-23.02
Effective Tax Rate	0.06%	0.05%	-0.08%	-0.07%	-0.05%	-0.01%

SEC Filings: 10-K · 10-Q